Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells-Reference-Cited by-同舟云学术

Combination simvastatin and metformin induces G1-phase cell cycle arrest and Ripk1- and Ripk3-dependent necrosis in C4-2B osseous metastatic castration-resistant prostate cancer cells

Published:2014-11 Issue:11 Volume:5 Page:e1536-e1536
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Babcook M A,Sramkoski R M,Fujioka H,Daneshgari F,Almasan A^ORCID,Shukla S,Nanavaty R R,Gupta S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2014500.pdf

Reference59 articles.

1. American Cancer Society. Cancer Facts & Figures 2014. American Cancer Society: Atlanta, GA, USA, 2014.

2. Cookson MS, Roth BJ, Dahm P, Engstrom C, Freedland SJ, Hussain M et al. Castration-resistant prostate cancer: AUA Guideline. J Urol 2013; 190: 429–438.

3. Loblaw DA, Walker-Dilks C, Winquist E, Hotte SJ, Genitourinary Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Systemic therapy in men with metastatic castration-resistant prostate cancer: a systematic review. Clin Oncol (R Coll Radiol) 2013; 25: 406–430.

4. Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351: 1502–1512.

5. Vander Heiden MG, Cantley LC, Thompson CB . Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324: 1029–1033.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer effects of simvastatin-loaded albumin nanoparticles on monolayer and spheroid models of breast cancer;Biochemical and Biophysical Research Communications;2024-11

2. Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation;Pharmaceuticals;2024-08-15

3. Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy;Clinical and Molecular Hepatology;2024-07-01

4. Crosstalk between metabolism and cell death in tumorigenesis;Molecular Cancer;2024-04-04

5. Stigmasterol Exerts an Anti-Melanoma Property through Down-Regulation of Reactive Oxygen Species and Programmed Cell Death Ligand 1 in Melanoma Cells;Antioxidants;2024-03-21